Cargando…

Mesenchymal stromal cells in myeloid malignancies

Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are clonal myeloid disorders characterized by hematopoietic insufficiency. As MDS and AML are considered to originate from genetic and molecular defects of hematopoietic stem and progenitor cells (HSPC), the main focus of research in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schroeder, Thomas, Geyh, Stefanie, Germing, Ulrich, Haas, Rainer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234241/ https://www.ncbi.nlm.nih.gov/pubmed/28090484 http://dx.doi.org/10.5045/br.2016.51.4.225

Ejemplares similares

Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia
por: Geyh, Stefanie, et al.
Publicado: (2018)

Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience
por: Jäger, Paul, et al.
Publicado: (2023)

Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment
por: Rautenberg, Christina, et al.
Publicado: (2019)

Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS
por: Rautenberg, Christina, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
por: Kapor, Suncica, et al.
Publicado: (2021)

A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): A case report
por: Schroeder, Thomas, et al.
Publicado: (2008)

Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation
por: Rautenberg, Christina, et al.
Publicado: (2020)

Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component
por: Platte, Victoria, et al.
Publicado: (2022)

Mesenchymal Stromal Cells as a Cellular Target in Myeloid Malignancy: Chances and Challenges in the Genome Editing of Stromal Alterations
por: Banjanin, Bella, et al.
Publicado: (2021)

Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature
por: Kuendgen, Andrea, et al.
Publicado: (2018)

A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies
por: Tomasoni, Chiara, et al.
Publicado: (2023)

Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies
por: Cominal, Juçara Gastaldi, et al.
Publicado: (2019)

Mesenchymal stromal cells for osteonecrosis
por: Elgaz, S., et al.
Publicado: (2020)

Mesenchymal stromal cells in the thymus
por: Nitta, Takeshi
Publicado: (2022)

Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells
por: Tan, Zhenya, et al.
Publicado: (2022)

Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?
por: Kasprzak, Annika, et al.
Publicado: (2021)

TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2(−/−)-Driven Myeloid Malignancy Progression
por: Li, Rong, et al.
Publicado: (2017)

Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications
por: Fracchiolla, Nicola Stefano, et al.
Publicado: (2017)

Are mesenchymal stromal cells immune cells?
por: Hoogduijn, Martin J
Publicado: (2015)

Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells
por: Coccè, Valentina, et al.
Publicado: (2021)

Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression
por: Cammarota, Francesca, et al.
Publicado: (2016)

The EHA Research Roadmap: Malignant Myeloid Diseases
por: Döhner, Hartmut, et al.
Publicado: (2021)

Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
por: Kuendgen, Andrea, et al.
Publicado: (2011)

Mesenchymal Stromal Cells and Viral Infection
por: Thanunchai, Maytawan, et al.
Publicado: (2015)

Gut Mesenchymal Stromal Cells in Immunity
por: Messina, Valeria, et al.
Publicado: (2017)

Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
por: Schroeder, Thomas, et al.
Publicado: (2023)

Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis
por: Boquoi, A., et al.
Publicado: (2022)

Mesenchymal stromal cells for cardiovascular disease
por: Copland, Ian B.
Publicado: (2011)

EZH2 in Myeloid Malignancies
por: Rinke, Jenny, et al.
Publicado: (2020)

Mechanisms of mesenchymal stem/stromal cell function
por: Spees, Jeffrey L., et al.
Publicado: (2016)

Recent advances in understanding mesenchymal stromal cells
por: Rendra, Erika, et al.
Publicado: (2020)

Mesenchymal Stem/Stromal Cells in Organ Transplantation
por: Deo, Dayanand, et al.
Publicado: (2022)

Mesenchymal stem/stromal cells in cancer therapy
por: Lan, Tianxia, et al.
Publicado: (2021)

Mesenchymal Stromal Cells in Ischemic Brain Injury
por: Brooks, Beverly, et al.
Publicado: (2022)

An Update on Applications of Cattle Mesenchymal Stromal Cells
por: Merlo, Barbara, et al.
Publicado: (2022)

Role of Mesenchymal Stem/Stromal Cells in Coagulation
por: Guillamat-Prats, Raquel
Publicado: (2022)

Mesenchymal Stromal Cells as a Driver of Inflammaging
por: Lyamina, Svetlana, et al.
Publicado: (2023)

Mesenchymal Stromal Cell Therapy in Lung Transplantation
por: Nykänen, Antti I., et al.
Publicado: (2023)

Mesenchymal Stromal Cells: Heterogeneity and Therapeutical Applications
por: Ouzin, Meryem, et al.
Publicado: (2023)

Mesenchymal Stem/Stromal Cells for Therapeutic Angiogenesis
por: Mohamad Yusoff, Farina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1026giu8fre4pd1fooji6aqsmd